a
Biogenetech

Related Posts

    Sorry, no posts matched your criteria.

Title Image

Blood Derivatives

หน้าแรก   /   Products   /   Blood Derivatives

(Equine antirabies immunoglobulin fragments)

Indication : VINRAB 1000 IU provides passive immunization against rabies for prevention of rabies in patients at risk of being exposed to rabies after contact with a rabid animal or an animal presumed to be rabid. Antirabies serum itself does not constitute an antirabies treatment and should always be used in conjunction with rabies vaccine.

(Enzyme Refined, Equine Tetanus Antitoxic Immunoglobulin Fragments)

Indication : Tetanus Antitoxin has been used to provide passive immunity against Tetanus.

(Enzyme refined, Equine Diphtheria antitoxic immunoglobulin fragments)

Indication : Diphtheria antitoxin has been used to provide passive immunity against Diphtheria.

(total plasma proteins to 20%, of which human albumin at least to 95%.)

Indication : Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.
The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

(Human tetanus immunoglobulin)

Indication : 1. Post-exposure prophylaxis
Immediate prophylaxis after tetanus prone injuries in patients not adequately vaccinated, in patients whose immunisation status is not known with certainty, and in patients with severe deficiency in antibody production.

2. Therapy of clinically manifest tetanus
Active tetanus vaccination should always be administered in conjunction with tetanus immunoglobulin unless there are contraindications or confirmation of adequate vaccination.

(Human hepatitis B immunoglobulin)

Indication : • Prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure;
• Immunoprophylaxis of hepatitis B
   - In case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown)
   - In haemodialysed patients, until vaccination has become effective
   - In the newborn of a hepatitis B virus carrier-mother
   - In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.

(Human normal immunoglobulin (IgIV))

Indication : Replacement therapy in adults, and children and adolescents (0-18 years) in:
• Primary immunodeficiency syndromes with impaired antibody production.
• Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
• Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
• Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
• Congenital AIDS with recurrent bacterial infections.

Immunomodulation in adults, and children and adolescents (0-18 years) in:
• Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
• Guillain Barré syndrome.
• Chronic Inflammatory Demyelinating Poliradiculoneuropathy (CIDP).
• Kawasaki disease.

(Human hepatitis B immunoglobulin)

Indication : • Prevention of hepatitis B virus recurrence after liver transplantation for hepatitis B virus induced liver failure in combination with antiviral therapy.
• Immunoprophylaxis of hepatitis B:
   - In case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown)
   - In haemodialysed patients, until vaccination has become effective
   - In the newborn of a hepatitis B virus carrier-mother
   - In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.
rus.